Patents by Inventor Sun Woo Lim

Sun Woo Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240163278
    Abstract: Disclosed is a user authentication-based packet classification method and apparatus for providing differentiated security services in a ship network. A user authentication-based packet classification method includes receiving an authorization code request message from a user terminal including a client, authenticating and authorizing a user of the client based on the authorization code request message, transmitting an authorization code response message to the user terminal in response to the authorization code request message, receiving an access token request message from the user terminal based on the authorization code response message, and transmitting an access token response message including an access token to the user terminal in response to the access token request message.
    Type: Application
    Filed: August 7, 2023
    Publication date: May 16, 2024
    Inventors: Jin Hyeok OH, Keon YUN, Sun Woo YUN, Sang Min LEE, Myong Cheol LIM, Sang Gyoo SIM, Tae Gyun KIM
  • Publication number: 20240131027
    Abstract: The present invention relates to a pharmaceutical composition comprising a novel compound as an active ingredient for prevention or treatment of transplant rejection. The novel compound SD911 of the present invention was identified to repress the migration of immune cells, increase the engraftment and viability of a grafted tissue, and regulate immune cells. In addition, it was found in a kidney transplantation model that the compound restrained human PBMC from suppressing the engraftment and damaging renal tissues and downregulated the expression of the inflammatory cytokine IL-17, with the consequent effective prevention and treatment of transplant rejection.
    Type: Application
    Filed: April 6, 2022
    Publication date: April 25, 2024
    Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Chul Woo YANG, Dongyun SHIN, Sun Woo LIM, Mi La CHO, Yoo Jin SHIN, Seon Yeong LEE, A Ram LEE
  • Patent number: 11938247
    Abstract: Provided are a method for fabricating a human nasal turbinate-derived mesenchymal stem cell-based 3D bioprinted construct, and a use thereof, wherein the human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted construct is advantageous over conventional mesenchymal stem cell-based, 3D bioprinted constructs in that the former can survive and proliferate stably in vitro and/or in vivo and shows high osteogenic differentiation ability as well, therefore is expected to make a great contribution to the practical use of cellular therapeutic agents.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: March 26, 2024
    Assignee: CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Sung Won Kim, Jung Yeon Lim, Sun Hwa Park, Byeong Gon Yoon, Dong-Woo Cho, Jinah Jang, Seok Won Kim
  • Publication number: 20230095498
    Abstract: Provided is a novel compound and use thereof which has an excellent immunological regulation ability while not exhibiting toxicity in vivo, and has no nephrotoxicity and rather has a kidney protective effect, and thus can be used for the treatment of immune diseases such as autoimmune diseases caused by abnormal regulation of various immune responses, inflammatory diseases, and transplant rejection diseases. A transplant rejection avatar animal model was confirmed to be humanized, by confirming an increase in serum creatinine, an indicator of transplant rejection in a patient, an increase in human CD4-positive cells, and infiltration of inflammatory cytokine IL-17 into kidney tissue of the animal model. It was confirmed that, when an immunosuppressant is administered, the increased serum creatinine, human CD4-positive cells, and the infiltration of inflammatory cytokine IL-17 are reduced, and thus an animal model, in which the immune status of a patient is reflected, is effectively constructed.
    Type: Application
    Filed: January 14, 2021
    Publication date: March 30, 2023
    Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Chul-Woov YANG, Dong-Yun SHIN, Mi-La CHO, Seon-Yeong LEE, Sun-Woo LIM, Yoo-Jin SHIN
  • Publication number: 20180256519
    Abstract: The present invention relates to a composition for preventing or treating mitochondrial diseases caused by immunosuppressants, and immune diseases, containing metformin and, more specifically, to a composition for treating mitochondrial diseases caused by immunosuppressants, containing metformin; a pharmaceutical composition for preventing or treating immune diseases, containing, as active ingredients, metformin and an immunosuppressant, which is a target of rapamycin inhibitor (mTOR inhibitor); and a pharmaceutical composite formulation for preventing or treating immune diseases, containing, as ingredients, metformin and a mammalian target of rapamycin inhibitor, wherein the metformin and mammalian target of rapamycin inhibitor are administered simultaneously or separately, or administered in a predetermined sequence.
    Type: Application
    Filed: February 23, 2018
    Publication date: September 13, 2018
    Inventors: Mi La Cho, Chul Woo Yang, Sung Hwan Park, Seon Yeong Lee, Min Jung Park, Joo Yeon Jhun, Sun Woo Lim, Byung Ha Chung, Eun Kyung Kim, Jae Kyung Kim, Hyun-Sik Na, Se-Young Kim, Eun Jung Lee, Hyeon-Beom Seo
  • Patent number: 10016376
    Abstract: Provided is a composition for alleviating nephrotoxicity caused by an immunosuppressive drug, including metformin, and a composition for preventing or treating an immune disease, including the same. Further, the composition provided can be useful in improving a treatment effect on diseases requiring immunosuppression by effectively alleviating a decline in renal function caused due to side effects of conventional immunosuppressive drugs, and can also be useful in preventing or treating organ transplant rejection, autoimmune diseases, inflammatory diseases and the like since various methods of co-administering a conventional immunosuppressive drug and metformin are suggested to reduce nephrotoxic side effects of conventional immunosuppressive drugs and maximize immunosuppressive or immunomodulatory effects.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: July 10, 2018
    Assignee: The Catholic University of Korea Industry-Academic Cooperation Foundation
    Inventors: Mi La Cho, Chul Woo Yang, Jong Young Choi, Sung Hwan Park, Min Jung Park, Seon Yeong Lee, Joo Yeon Jhun, Eun Jung Lee, Jae Kyung Kim, Eun Kyung Kim, Sun Woo Lim
  • Publication number: 20170348256
    Abstract: Provided is a composition for alleviating nephrotoxicity caused by an immunosuppressive drug, including metformin, and a composition for preventing or treating an immune disease, including the same. Further, the composition provided can be useful in improving a treatment effect on diseases requiring immunosuppression by effectively alleviating a decline in renal function caused due to side effects of conventional immunosuppressive drugs, and can also be useful in preventing or treating organ transplant rejection, autoimmune diseases, inflammatory diseases and the like since various methods of co-administering a conventional immunosuppressive drug and metformin are suggested to reduce nephrotoxic side effects of conventional immunosuppressive drugs and maximize immunosuppressive or immunomodulatory effects.
    Type: Application
    Filed: December 18, 2015
    Publication date: December 7, 2017
    Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRYACADEMIC COOPERATION FOUNDATION
    Inventors: Mi La CHO, Chul Woo YANG, Jong Young CHOI, Sung Hwan PARK, Min Jung PARK, Seon Yeong LEE, Joo Yeon JHUN, Eun Jung LEE, Jae Kyung KIM, Eun Kyung KIM, Sun Woo LIM
  • Patent number: 8858116
    Abstract: The present invention relates to a road restoration block for covering eliminated pavements during various road constructions conducted by eliminating some of or the entire existing road pavements, and more specifically, to a road restoration block, which can quickly and safely cover the eliminated pavements by providing blocks that are simply carried, disposed, and disassembled with strong coupling power to the upper part of the eliminated pavements so that people and cars may pass even when the constructions are in progress, thereby providing a safe and pleasant construction environment by preventing the traffic congestion caused by the constructions.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: October 14, 2014
    Inventor: Sun Woo Lim
  • Publication number: 20120237294
    Abstract: The present invention relates to a road restoration block for covering eliminated pavements during various road constructions conducted by eliminating some of or the entire existing road pavements, and more specifically, to a road restoration block, which can quickly and safely cover the eliminated pavements by providing blocks that are simply carried, disposed, and disassembled with strong coupling power to the upper part of the eliminated pavements so that people and cars may pass even when the constructions are in progress, thereby providing a safe and pleasant construction environment by preventing the traffic congestion caused by the constructions.
    Type: Application
    Filed: October 26, 2010
    Publication date: September 20, 2012
    Inventor: Sun Woo Lim